Metropolitan Life Insurance Company (MetLife)’s ForeScout Technologies, Inc. Common Stock FSCT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio FSCT Stock Details FSCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,852	Closed	-$315K	–	2614
2020 Q2	$315K	Buy	14,852 +1,687	+13%	+$45.9K	0.01%	1517
2020 Q1	$416K	Hold	13,165	–	–	0.01%	1161
2019 Q4	$432K	Hold	13,165	–	–	0.01%	1421
2019 Q3	$499K	Buy	13,165 +2,895	+28%	+$106K	0.01%	1296
2019 Q2	$348K	Buy	10,270 +796	+8%	+$29.2K	0.01%	1525
2019 Q1	$397K	Hold	9,474	–	–	0.01%	1444
2018 Q4	$246K	Hold	9,474	–	–	﹤0.01%	1666
2018 Q3	$358K	Buy	+9,474	New	+$343K	0.01%	1607

Metropolitan Life Insurance Company (MetLife)'s FSCT Position: Q3 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ForeScout Technologies, Inc. Common Stock (FSCT) in Q3 2020, closing a stake of 14,852 shares — an estimated $315K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in FSCT in Q3 2018 and held it in 8 quarters. The position peaked at $499K in Q3 2019. 0 funds tracked by Wall St. Rank hold FSCT as of Q3 2020.

Metropolitan Life Insurance Company (MetLife) reported no remaining ForeScout Technologies, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 14,852 ForeScout Technologies, Inc. Common Stock shares in Q3 2020, an estimated $315K.
Metropolitan Life Insurance Company (MetLife) first reported a position in ForeScout Technologies, Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s ForeScout Technologies, Inc. Common Stock position peaked at $499K in Q3 2019.
0 funds tracked by Wall St. Rank held ForeScout Technologies, Inc. Common Stock as of Q3 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2020, filed 13 Nov 2020.